Signaling pathways
-
BA5862 PavurutamabSummary: Pavurutamab (AMG-701) is a bispecific T-cell splicer molecule against and anti-B-cell maturation antigen. - BA5863 PacanalotamabSummary: Pacanalotamab (AMG420; BI-836909) is a bispecific T cell engager (BiTE).
- BA5864 PasotuxizumabSummary: Pasotuxizumab (BAY2010112) is a bispecific T-cell engager (BiTE).
- BA5865 VoxalatamabSummary: Voxalatamab (JNJ-63898081) is a conjugateable bispecific antibody.
- BA5866 VibecotamabSummary: Vibecotamab (XmAb14045) is a potent bispecific antibody that stimulates T cell-mediated targeted killing of CD123-expressing cells.
- BA5867 VepsitamabSummary: Vepsitamab (AMG199) is an anti-BiTE antibody.
- BA5868 UbamatamabSummary: Ubamatamab (REGN4018) is a bispecific antibody targeting mucin 16 and humanized.
- BA5869 MK-0159Summary: MK-0159 is an orally active and selective inhibitor at 22, 3 and 70 nM for human, mouse and rat, respectively.
- BA5871 AB-680Summary: AB-680 is a potent, reversible, selective inhibitor of (extracellular nucleotidase).
- BA5872 PSB-12379Summary: PSB-12379 is a nucleotide analog.